Ibogaine treatment results data can be confusing when you first start looking. You may see dramatic personal stories on one side and serious safety warnings on the other. This guide helps you sort through that noise so you can understand what the research and observational ibogaine treatment results data actually show about outcomes, risks, and what realistically affects your chances of success.
You will not find a single simple “success rate” here, because that does not exist yet for ibogaine. Instead, you will see what is known from real studies, what is still unknown, and which factors are in your control as you compare ibogaine to other options.
Understand what ibogaine can and cannot do
Ibogaine is not a magic cure for addiction, PTSD, or depression, even though some people have life changing experiences. What it does appear to do, based on current ibogaine treatment results data, is help you transition from a dependent state to a non dependent state with less acute withdrawal and less short term depression, while long term abstinence varies a lot from person to person [1].
You should think of ibogaine more as a strong catalyst than a stand alone solution. It can rapidly interrupt withdrawal, decrease craving for a time, and open a psychological window of opportunity. What you do with that window, through integration, therapy, and lifestyle changes, plays a major role in whether the benefits last. If you want a deeper overview of how this compares with other modalities, you can also explore how effective is ibogaine therapy.
Know the kinds of data available
When you look for ibogaine treatment results data, you are not seeing the same kind of evidence you might see for an FDA approved medication. As of 2024, ibogaine remains a Schedule I substance in the United States and does not have large, randomized controlled trials behind it. Most of what you can rely on today falls into three main types.
Observational studies and follow ups
Several research groups have tracked people before and after ibogaine treatment and then followed them for months or years:
- Observational cohorts from clinics, especially in Mexico and Brazil
- Legal treatment programs in countries like New Zealand
- Surveys of people who received ibogaine in hospital or residential settings
These studies look at real world ibogaine addiction recovery success and include long term follow up, but they are not randomized. That means you get useful patterns and trends, but you cannot say ibogaine alone caused every outcome.
Case reports and safety reviews
There are also detailed single patient case reports and pooled reviews of adverse events. For example, a 2016 case report describes a 40 year old man who took 4 g of ibogaine plus a booster for heroin withdrawal and went into cardiac arrest within 8 hours, leading to brain death [2]. A broader review from 1990 to 2008 identified 19 deaths linked to ibogaine, with 15 related to detox attempts and 6 involving serious cardiac complications such as fatal arrhythmias [2].
These reports do not tell you how often problems happen in a properly screened medical setting, but they clearly show that ibogaine has real medical risks and is not safe to experiment with on your own.
Early clinical research and new trials
More formal research is starting to emerge. A MAPS funded study of 30 people treated for addiction in Mexico found notable improvements but had limitations, including lost follow ups and a definition of “opioid use” that counted buprenorphine or methadone maintenance as continued use, which probably underestimated some success [1]. Comparative analyses of several studies suggest ibogaine outcomes are often better than typical existing treatments for some individuals, especially with respect to withdrawal relief and short term abstinence [1].
In 2024, Texas funded a 50 million dollar, multi center ibogaine trial to study addiction and traumatic brain injury in a rigorous medical setting, with the explicit goal of pursuing eventual FDA approval [3]. This is the first large scale US initiative to systematically evaluate ibogaine’s safety and effectiveness and it will shape future ibogaine treatment effectiveness research for years to come.
Review ibogaine outcomes for opioid use
If you are struggling with opioids, you are probably most interested in concrete numbers. While there is no single official ibogaine treatment success rate, several observational studies give you a clearer picture of what ibogaine success for opioid recovery can look like in practice.
Mexico clinic observational study
One of the largest datasets comes from an observational study of 88 people treated with ibogaine for problematic opioid use at a single clinic in Mexico between 2012 and 2015 [4]. At follow up:
- 80 percent said ibogaine eliminated or drastically reduced withdrawal during treatment
- 50 percent reported reduced opioid craving after treatment
- 25 percent said their reduced craving lasted at least 3 months
When researchers looked at abstinence and longer term patterns:
- 30 percent reported complete abstinence from opioids after ibogaine
- Among those abstinent, 54 percent had stayed abstinent at least 1 year and 31 percent for 2 or more years
- Across all participants, 41 percent reported more than 6 months of sustained abstinence at the time of the survey
Relapse was still common:
- 70 percent relapsed at some point after treatment
- Of those who relapsed, 48 percent still ended up using less opioids than before ibogaine
- Another 11 percent eventually achieved abstinence even after relapse [4]
Importantly, people who responded best to treatment, meaning they abstained or significantly reduced opioid use, also reported:
- Lower depression and anxiety scores
- Higher subjective well being
- More spiritual meaning and deeper insight into the causes of their addiction during the ibogaine experience
This supports the idea that both the biological and psychological aspects of ibogaine matter. If you want a focused breakdown of these patterns, you can also read ibogaine success for opioid recovery.
New Zealand 12 month follow up
A smaller but more tightly monitored study followed 14 opioid dependent individuals in New Zealand who received a single legal ibogaine treatment, with health professionals involved throughout [5]. Researchers measured addiction severity and depression using validated scales:
- Among the 8 people who completed all interviews, opioid use severity scores dropped significantly from baseline to 12 months (p = 0.002)
- Depression scores on the Beck Depression Inventory II also decreased significantly over the same period (p < 0.001)
- Acute withdrawal symptoms improved immediately after treatment in all 14 participants, based on the Subjective Opioid Withdrawal Scale (p = 0.015)
However, there was one death during treatment in this study [5]. That event underscores both sides of the picture for ibogaine therapy results statistics. You see meaningful improvements in use and mood for many, but you also see why cautious medical supervision and full cardiac screening are non negotiable.
Look at outcomes for other substances
Although opioids are the best studied, ibogaine effectiveness for substance use goes beyond a single drug category. Data is thinner, but some research gives you direction.
An observational study in Brazil looked at ibogaine treatment in a hospital setting combined with psychotherapy. This program focused on people with lifetime use of alcohol, cannabis, cocaine, and crack, capturing stimulant addiction in particular [1]. The results suggested potential effectiveness across these substances, although precise long term abstinence percentages were not the main emphasis of the report.
Overall, existing ibogaine effectiveness for substance use outside opioids suggests:
- Stronger and more predictable withdrawal relief for opioids than for alcohol or stimulants
- A mix of reduced craving, improved mood, and meaningful psychological insight for many people, regardless of the substance
- A similar pattern where some maintain abstinence or major reduction, while others relapse and still benefit from partial reduction in use
If you want to compare across different substances in more detail, it is helpful to look at multiple perspectives, including does ibogaine work for addiction and ibogaine treatment effectiveness research.
Consider ibogaine’s impact on PTSD, TBI, and mood
Newer ibogaine treatment results data goes beyond addiction to look at post traumatic stress disorder, traumatic brain injury, and overall functioning. If you live with both substance use and trauma, this is especially relevant.
Stanford study in special operations veterans
In 2024, Stanford Medicine published results from a study of 30 special operations veterans with traumatic brain injuries who received ibogaine combined with magnesium in a medical setting [6]. The changes one month after treatment were striking:
- PTSD symptoms decreased by 88 percent
- Depression symptoms decreased by 87 percent
- Anxiety symptoms decreased by 81 percent
Functioning also shifted:
- Average disability scores on the WHO Disability Assessment Scale went from 30.2, mild to moderate disability, down to 5.1, a range consistent with no disability [6]
Neuroimaging suggested that improvements in executive function were linked with increased theta brain waves, while reduced PTSD symptoms were linked with less complex cortical activity patterns [6]. In other words, the brain appeared to be functioning more efficiently.
Notably, this study reported no serious side effects or heart complications during treatment when participants were carefully screened and monitored. The most common issues were headaches and nausea, which were temporary [6].
These are early findings in a specific, highly selected group of veterans, not the general population. Still, they support the idea that ibogaine can deeply affect both mood and functioning, especially when trauma and brain injury are part of the picture.
Understand how ibogaine works in the brain
To make sense of ibogaine long term recovery outcomes, it helps to know how the medicine interacts with your brain. Ibogaine and its primary metabolite, noribogaine, affect several neurotransmitter systems at once, including:
- Opioid receptors
- Serotonin receptors
- NMDA receptors
- Dopamine receptors
They also stimulate the production of glial cell derived neurotrophic factor, GDNF, and brain derived neurotrophic factor, BDNF, which support neuroplasticity and help your brain adapt and recover from addiction related changes [1].
This multi system action may explain why some people feel like they receive weeks or months of emotional processing in a short period, why withdrawal can drop so quickly, and why mood often improves. It may also help explain why long term outcomes depend so heavily on what you do after treatment. Neuroplasticity is a window of opportunity, not a guarantee.
If you want a more comprehensive scientific overview, resources like ibogaine therapy results statistics and ibogaine long term recovery outcomes can help you place these mechanisms in context.
Ibogaine appears to create a powerful but time limited opportunity for change by easing withdrawal, improving mood, and increasing neuroplasticity. How you prepare and integrate has a major influence on whether that opportunity translates into lasting recovery.
Balance potential benefits with real risks
When you evaluate ibogaine treatment results data, safety has to be part of the same conversation as effectiveness. Ibogaine is not like taking a standard antidepressant. It can significantly stress your cardiovascular system, especially if you have underlying issues.
A detailed 2016 medical review linked ibogaine to:
- Prolonged QTc intervals, up to 588 ms in one case
- Torsades de pointes
- Seizures
- Sudden death
- Fatal arrhythmias
This review identified 19 deaths between 1990 and 2008 that were attributed to ibogaine, many in the context of detox attempts and several involving cardiac complications [2]. The case of the 40 year old man who self administered 4 g plus an undocumented booster is a clear example of ibogaine associated cardiotoxicity and fatal cardiac arrest [2].
Regulatory agencies have been cautious partly for this reason. Although ibogaine has been used to ease opiate withdrawal for more than 50 years, there were no completed formal controlled human trials as of 2016 due to safety and regulatory concerns [2]. Meanwhile, illegal status in the United States has pushed treatment into unregulated settings around the world, including self administration and informal centers without consistent safety protocols [2].
For your own safety, any consideration of ibogaine should include:
- Full cardiac evaluation, including ECG and screening for QT prolongation
- Review of medications that might interact with ibogaine or affect heart rhythm
- Liver function tests and general medical assessment
- A setting where continuous monitoring and emergency care are available
This is not a treatment to attempt on your own or in a casual environment.
Pay attention to factors that influence outcomes
The most honest way to think about ibogaine treatment results data is to accept that variability is the rule, not the exception. Two people can go to the same clinic and have very different long term results. Some key factors are within your control, and others are not.
Your preparation and mindset
People who approach ibogaine with clear intentions, realistic expectations, and a plan for what comes next are more likely to turn the acute benefits into durable change. In the Mexico opioid study, treatment responders described their ibogaine sessions as more spiritually meaningful and insight rich than non responders [4]. That suggests that psychological engagement during the experience may be part of why outcomes differ.
Quality of medical screening and monitoring
Given the documented cardiac and neurological risks, high quality medical oversight does more than keep you physically safe. It also allows you to engage more fully in the process without having to worry about basic health issues. Studies from New Zealand and Stanford highlight that when ibogaine is given in controlled environments, you can see both strong results and acceptable safety, although risks never drop to zero [7].
Integration and ongoing support
Across multiple studies, long term positive outcomes are closely linked to what happens after the session:
- Ongoing therapy or counseling
- Peer support or recovery communities
- Life structure changes, like housing, employment, and relationships
- Continued attention to mental health, including PTSD, depression, or anxiety
The PMC study of 88 opioid users suggested that the spiritual and insightful aspects of ibogaine may drive long term reductions in use, especially when integrated through supportive interventions [4]. If you do not have a plan for integration before you start, it is easy to lose momentum once you return home.
Your unique biology and history
Finally, your genetics, medical conditions, medications, trauma history, and substance use patterns all affect how you respond. That is why there is no single ibogaine treatment success rate that accurately predicts your personal outcome. Patterns will become clearer as more large scale ibogaine treatment effectiveness research is completed, especially through efforts like the Texas IMPACT consortium [3].
Use the data to guide your next steps
When you pull all of this ibogaine treatment results data together, a few grounded conclusions emerge:
- Ibogaine can significantly reduce acute withdrawal and craving for many, especially with opioids
- A meaningful minority achieve long term abstinence, and many others reduce use or improve functioning
- Depression, anxiety, PTSD symptoms, and overall disability can improve substantially for some people, especially in structured, medically supervised settings
- Serious cardiac risks are real and documented, so thorough screening and professional monitoring are essential
- Long term outcomes are highly variable and depend heavily on preparation, integration, and your broader recovery environment
Your responsibility is to treat ibogaine as one potential tool among many, not a guaranteed cure. As you compare options, use resources like ibogaine addiction recovery success, ibogaine treatment success rate, and ibogaine effectiveness for substance use to deepen your understanding and frame specific questions for any provider you consider.
Ultimately, the most honest way to approach ibogaine is to pair respect for its potential with equal respect for its risks, and to commit to the hard work of recovery before, during, and long after any single treatment session.
References
- (Ambio Life Sciences)
- (PMC)
- (UTHealth Houston)
- (PMC)
- (PubMed)
- (Stanford Medicine)
- (PubMed, Stanford Medicine)






















